GLP-1 receptor agonists and DPP-4 inhibitors are included in the 2012 American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) and 2013 American Association of Clinical Endocrinologists (AACE) guidelines as second-line therapy for patients who do not achieve glycemic control with metformin therapy and lifestyle modifications alone
PLOS One 9:e97774 Saika A, Koike H, Yamamoto S, Kishimoto T, Morita T (2017) Enhanced production of a diastereomer type of mannosylerythritol lipid-B by the basidiomycetous yeast Pseudozyma tsukubaensis expressing lipase genes from Pseudozyma antarctica
Ready to Switch to Shotsy
Once enrolled, medications are shipped directly to your door or sent to a pharmacy near you
Gastroenterology 40 (3), 250258
It's an excellent opportunity to enjoy ongoing savings while exploring the full spectrum of health and wellness offerings from IAM Worldwide.Contact Us